ABBV - AbbVie Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts15162125
Avg. Estimate2.912.8310.9511.07
Low estimate2.762.5510.639.58
High estimate2.993.111.1412.35
Year ago EPS3.373.6613.7710.95
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts13132424
Avg. Estimate13.48B13.38B52.66B52.35B
Low estimate12.95B13.08B52B49.42B
High estimate13.67B13.65B54.19B55.16B
Year ago sales14.58B14.91B58.05B52.66B
Sales growth (year/est)-7.60%-10.20%-9.30%-0.60%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS3.313.573.562.46
Actual EPS3.373.663.62.46
Difference0.060.090.040
Surprise %1.80%2.50%1.10%0.00%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate2.912.8310.9511.07
7 days ago2.932.8310.9611.07
30 days ago2.62.529.769.85
60 days ago2.872.8311.0611.18
90 days ago2.872.8511.0811.12
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/A11
Up last 30 days2223
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABBVIndustrySector(s)S&P 500
Current qtr.-13.60%N/AN/AN/A
Next qtr.-22.70%N/AN/AN/A
Current year-20.50%N/AN/AN/A
Next year1.10%N/AN/AN/A
Next 5 years (per annum)-4.17%N/AN/AN/A
Past 5 years (per annum)13.15%N/AN/AN/A